Enlargement rate of geographic atrophy before and after secondary CNV conversion with associated anti-VEGF treatment
Abstract Background To study the enlargement rate of primary geographic atrophy (GA) before and after diagnosis of a secondary choroidal neovascularization (CNV) treated with anti-vascular endothelial growth factor (VEGF) therapy. Methods Five hundred twenty-two consecutive eyes with primary GA were...
Main Authors: | Jakob Siedlecki, Caroline Koch, Benedikt Schworm, Raffael Liegl, Thomas Kreutzer, Karsten U. Kortuem, Ricarda Schumann, Siegfried G. Priglinger, Armin Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-020-01766-6 |
Similar Items
-
Beyond the Visual Acuity: Assessing the Visual Function in mCNV Patients After Anti-VEGF Treatment
by: Songshan Li, et al.
Published: (2021-08-01) -
Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy
by: Benedikt Schworm, et al.
Published: (2021-06-01) -
Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
by: Leonie F. Keidel, et al.
Published: (2021-04-01) -
Intravitreal Avastin for managing CNV due to age-related macular degeneration
by: Quan - Liang Zhao, et al.
Published: (2013-05-01) -
Recent advance on anti-VEGF treatment of choroidal neovascularization secondary to pathological myopia
by: Xing-Zhao Xu, et al.
Published: (2018-09-01)